Stoneridge Investment Partners’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,872
Closed -$31K 352
2016
Q3
$31K Sell
2,872
-14
-0.5% -$208 ﹤0.01% 260
2016
Q2
$50K Hold
2,886
0.01% 276
2016
Q1
$108K Sell
2,886
-1,119
-28% -$44.7K 0.02% 282
2015
Q4
$273K Sell
4,005
-1,729
-30% -$124K 0.04% 244
2015
Q3
$331K Sell
5,734
-338
-6% -$29.9K 0.05% 234
2015
Q2
$480K Sell
6,072
-456
-7% -$30.7K 0.06% 214
2015
Q1
$442K Buy
6,528
+188
+3% +$12.1K 0.05% 214
2014
Q4
$246K Buy
6,340
+3,218
+103% +$130K 0.03% 229
2014
Q3
$136K Buy
3,122
+1,138
+57% +$53.3K 0.02% 235
2014
Q2
$119K Sell
1,984
-34
-2% -$1.9K 0.02% 221
2014
Q1
$158K Sell
2,018
-1,849
-48% -$143K 0.03% 197
2013
Q4
$236K Buy
+3,867
New +$225K 0.05% 175

Other funds holding FCSC

Stoneridge Investment Partners's FCSC Position: Q4 2016 in Review

Stoneridge Investment Partners sold out of Fibrocell Science Inc. (FCSC) in Q4 2016, closing a stake of 2,872 shares — an estimated $31K sold.

Stoneridge Investment Partners first reported a position in FCSC in Q4 2013 and held it in 12 quarters. The position peaked at $480K in Q2 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q4 2016.

  • Stoneridge Investment Partners reported no remaining Fibrocell Science Inc. position as of Q4 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 2,872 Fibrocell Science Inc. shares in Q4 2016, an estimated $31K.
  • Stoneridge Investment Partners first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 12 quarters.
  • Stoneridge Investment Partners's Fibrocell Science Inc. position peaked at $480K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2016.

Based on Stoneridge Investment Partners's 13F filing for Q4 2016, filed 27 Jan 2017.